Does dual vs. triple antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation lower the risk of bleeding at the cost of increased risk of ischemic events?()

Detalles Bibliográficos
Autores principales: Gupta, Kartik, Prejean, Shane P., Vaduganathan, Muthiah, Golwala, Harsh, Watts, Thomas Evan, Aryal, Sudeep R., von Mering, Gregory, Booker, Oscar Julian, Ahmed, Mustafa I., Bajaj, Navkaranbir S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859524/
https://www.ncbi.nlm.nih.gov/pubmed/31763435
http://dx.doi.org/10.1016/j.ijcha.2019.100404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859524/
https://www.ncbi.nlm.nih.gov/pubmed/31763435
http://dx.doi.org/10.1016/j.ijcha.2019.100404

Ejemplares similares